Bupropion Hydrobromide
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Bupropion Hydrobromide is used to treat attention deficit disorder with hyperactivity, depressive disorder and tobacco use disorder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 23, 2008.
Bupropion Hydrobromide is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $70.87 to $212.48 per EA — the most expensive product costs about 3.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$70.87 – $212.48
per EA
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing BUPROPION HYDROBROMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
APLENZIN ER 522 MG TABLET | $212.4769 per EA | — |
APLENZIN ER 348 MG TABLET | $93.5116 per EA | — |
APLENZIN ER 174 MG TABLET | $70.8674 per EA | — |
Frequently Asked Questions
What is Bupropion Hydrobromide used to treat?
Bupropion Hydrobromide is used to treat attention deficit disorder with hyperactivity, depressive disorder and tobacco use disorder, per the National Library of Medicine's MED-RT classification.
How many Bupropion Hydrobromide products are on the market?
The Bupropion Hydrobromide drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Bupropion Hydrobromide?
NADAC reference prices for Bupropion Hydrobromide range from $70.8674 to $212.4769 per EA — the most expensive product costs about 3.0× the cheapest.
Which manufacturers make Bupropion Hydrobromide?
1 manufacturer lists Bupropion Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Bausch Health US LLC (3).